Wednesday, July 8, 2026

biotech · Hypertrophic Cardiomyopathy · Arrhythmogenic Right Ventricular Cardiomyopathy · TNYA

Tenaya Therapeutics

Tenaya Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

South San Francisco, USA HQ
2016 Founded
99 Employees
Public company Type
TNYA · NYSE Ticker
Company details
Status
Public
HQ
South San Francisco, USA
Founded
2016
Employees
99
Programs
2
Drugs
1
Patents
13
Intelligence · Clinical Programs

Tenaya Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Tenaya Therapeutics.

Tenaya Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TN-201

    Tenaya Therapeutics

    Hypertrophic Cardiomyopathy

    phase 2 gene therapy active

    1 trial

Frequently asked questions

How many clinical projects does Tenaya Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.